News
The FDA said yesterday that it is investigating the deaths from liver failure of two non-ambulatory boys with Duchenne ...
The Food and Drug Administration said Wednesday it was expanded existing warnings on the two leading COVID vaccines about a ...
The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.
Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherap ...
ROCKVILLE, MD, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- The global ammonia caramel market is poised for significant ...
2d
Stockhead on MSNHealth Check: UBS turns ultra-bullish on Aussie healthcare leadersBroker UBS believes the three-year rout of ASX healthcare stocks is near an end and it has promoted Cochlear and Resmed to ...
A nationwide recall has been issued for a common type of chocolate due to “risk of serious or life-threatening allergic ...
TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...
Citizens Capital Markets and Raymond James are acting as the joint book-running managers for the proposed offering. Lake Street Capital Markets, LLC is acting as financial advisor to Achieve in the ...
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package ...
RFK Jr. turned the CDC's vaccine committee into an anti-vaccine panel, but it still heard evidence that his campaign against ...
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results